Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
boston blog main
boston top stories
life sciences
meiragtx
3
×
national blog main
national top stories
new york blog main
new york top stories
novartis
spinal muscular atrophy
bill cassidy
biogen
biotech
boulder/denver blog main
boulder/denver top stories
celgene
deals
detroit blog main
detroit top stories
fda
gene therapy
indiana blog main
indiana top stories
ipo
johnson & johnson
mark warner
medicaid
medicare
national
parkinson's disease
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
What
bio
gene
roundup
years
age
allogene
alzheimer’s
bigger
biggest
cancer
come
companies
crispr
deal
different
diversity
drug
emerging
fail
gave
hot
immunotherapy
increases
investors
ipo
j
johnson
juno
latest
meiragtx
million
morning
nearly
new
past
pharmaceutical
plan
prescription
price
prices
Language
Current search:
meiragtx
×
photo
×
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More